- Class: 1
- Architecture: 1.20:Up-down Bundle
- Topology: 1.20.1640:Multidrug efflux transporter AcrB transmembrane fold
- Homology: 1.20.1640.10:Multidrug efflux transporter AcrB transmembrane domain
PDB Entries
PDB ID | OPM | Mutant | Chain Formula | Resolution | HETNAM | |||
---|---|---|---|---|---|---|---|---|
Amino Acid sequence | SCOPe Family Level | CATH Homology Level | ||||||
1iwg | [A3] | [A3] | [A3] | 3.5 | ||||
1oy6 | [A3] | [A3] | [A3] | 3.68 | ||||
1oy8 | [A3] | [A3] | [A3] | 3.63 | RHQ:RHODAMINE 6G | |||
1oy9 | [A3] | [A3] | [A3] | 3.8 | ET:ETHIDIUM | |||
1oyd | [A3] | [A3] | [A3] | 3.8 | DEQ:DEQUALINIUM | |||
1oye | [A3] | [A3] | [A3] | 3.48 | CPF:1-CYCLOPROPYL-6-FLUORO-4-OXO-7-PIPERAZIN-1-YL-1,4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID | |||
1t9t | [A3] | [A3] | [A3] | 3.23 | ||||
1t9u | [A3] | [A3] | [A3] | 3.11 | CPF:1-CYCLOPROPYL-6-FLUORO-4-OXO-7-PIPERAZIN-1-YL-1,4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID | |||
1t9v | [A3] | [A3] | [A3] | 3.8 | RHQ:RHODAMINE 6G | |||
1t9w | [A3] | [A3] | [A3] | 3.23 | NFN:6-[[(2-ETHOXY-1-NAPHTHALENYL)CARBONYL]AMINO]-3,3-DIMETHYL-7-OXO-4-THIA-1-AZABICYCLO[3.2.0]HEPTANE-2-CARBOXYLATE | |||
1t9x | [A3] | [A3] | [A3] | 3.08 | ET:ETHIDIUM | |||
1t9y | [A3] | [A3] | [A3] | 3.64 | MC2:N2-(L-PHENYLALANYL)-N1-(NAPHTHALENYL)-L-ARIGNINAMIDE | |||
2dhh | [A3] | [A3] | [A3] | 2.8 | ||||
2dr6 | [A3] | [A3] | [A3] | 3.3 | DM2:DOXORUBICIN | |||
2drd | [A3] | [A3] | [A3] | 3.1 | MIY:(4S,4AS,5AR,12AS)-4,7-BIS(DIMETHYLAMINO)-3,10,12,12A-TETRAHYDROXY-1,11-DIOXO-1,4,4A,5,5A,6,11,12A-OCTAHYDROTETRACENE-2-CARBOXAMIDE | |||
2gif | [A3] | [A3] | [A3] | 2.9 | FLC:CITRATE ANION | |||
2hqc | [A3] | [A3] | [A3] | 3.56 | ||||
2hqd | [A3] | [A3] | [A3] | 3.65 | ||||
2hqf | [A3] | [A3] | [A3] | 3.38 | ||||
2hqg | [A3] | [A3] | [A3] | 3.38 | ||||
2hrt | [A3] | [A3] | [A3] | 3 | FLC:CITRATE ANION | |||
2i6w | [A3] | [A3] | [A3] | 3.1 | ||||
2j8s | [A3B2] | [A3B2] | [A3B2] | 2.54 | LMT:DODECYL-BETA-D-MALTOSIDE LMU:DODECYL-ALPHA-D-MALTOSIDE | |||
2rdd | [A3B3] | [A3B3] | [A3B3] | 3.5 | AIC:(2S,5R,6R)-6-{[(2R)-2-AMINO-2-PHENYLETHANOYL]AMINO}-3,3-DIMETHYL-7-OXO-4-THIA-1-AZABICYCLO[3.2.0]HEPTANE-2-CARBOXYLIC ACID | |||
2v50 | [A3] | [A3] | [A3] | 3 | LMT:DODECYL-BETA-D-MALTOSIDE | |||
2w1b | [A3] | [A3] | [A3] | 3.85 | DXC:(3ALPHA,5BETA,12ALPHA)-3,12-DIHYDROXYCHOLAN-24-OIC ACID | |||
3aoa | [A3] | [A3] | [A3] | 3.35 | ||||
3aob | [A3] | [A3] | [A3] | 3.35 | RFP:RIFAMPICIN | |||
3aoc | [A3] | [A3] | [A3] | 3.34 | ERY:ERYTHROMYCIN A | |||
3aod | [A3] | [A3] | [A3] | 3.3 | MIY:(4S,4AS,5AR,12AS)-4,7-BIS(DIMETHYLAMINO)-3,10,12,12A-TETRAHYDROXY-1,11-DIOXO-1,4,4A,5,5A,6,11,12A-OCTAHYDROTETRACENE-2-CARBOXAMIDE RFP:RIFAMPICIN | |||
3d9b | [A3] | [A3] | [A3] | 3.42 | NI:NICKEL (II) ION | |||
3noc | [A3B2] | [A3B2] | [A3B2] | 2.7 | FME:N-FORMYLMETHIONINE | |||
3nog | [A3B2] | [A3B2] | [A3B2] | 3.34 | FME:N-FORMYLMETHIONINE | |||
3w9h | [A3] | [A3] | [A3] | 3.05 | P9D:[{2-[({[(3R)-1-{8-[(4-TERT-BUTYL-1,3-THIAZOL-2-YL)CARBAMOYL]-4-OXO-3-[(E)-2-(1H-TETRAZOL-5-YL)ETHENYL]-4H-PYRIDO[1,2-A]PYRIMIDIN-2-YL}PIPERIDIN-3-YL]OXY}CARBONYL)AMINO]ETHYL}(DIMETHYL)AMMONIO]ACETATE | |||
3w9i | [A3] | [A3] | [A3] | 2.71 | LMT:DODECYL-BETA-D-MALTOSIDE | |||
3w9j | [A3] | [A3] | [A3] | 3.15 | LMT:DODECYL-BETA-D-MALTOSIDE P9D:[{2-[({[(3R)-1-{8-[(4-TERT-BUTYL-1,3-THIAZOL-2-YL)CARBAMOYL]-4-OXO-3-[(E)-2-(1H-TETRAZOL-5-YL)ETHENYL]-4H-PYRIDO[1,2-A]PYRIMIDIN-2-YL}PIPERIDIN-3-YL]OXY}CARBONYL)AMINO]ETHYL}(DIMETHYL)AMMONIO]ACETATE | |||
4c48 | [A3B3C3] | [A3B3C3] | [A3B3C3] | 3.3 | LMT:DODECYL-BETA-D-MALTOSIDE NI:NICKEL (II) ION | |||
4cdi | [A3B3] | [A3B3] | [A3B3] | 3.7 | ||||
4dx5 | [A3B2] | [A3B2] | [A3B2] | 1.9 | C14:TETRADECANE D10:DECANE D12:DODECANE DD9:NONANE GOL:GLYCEROL HEX:HEXANE LMT:DODECYL-BETA-D-MALTOSIDE LMU:DODECYL-ALPHA-D-MALTOSIDE MIY:(4S,4AS,5AR,12AS)-4,7-BIS(DIMETHYLAMINO)-3,10,12,12A-TETRAHYDROXY-1,11-DIOXO-1,4,4A,5,5A,6,11,12A-OCTAHYDROTETRACENE-2-CARBOXAMIDE OCT:N-OCTANE SO4:SULFATE ION UND:UNDECANE | |||
4dx6 | [A3B2] | [A3B2] | [A3B2] | 2.9 | LMT:DODECYL-BETA-D-MALTOSIDE | |||
4dx7 | [A3B2] | [A3B2] | [A3B2] | 2.25 | D10:DECANE D12:DODECANE DM2:DOXORUBICIN GOL:GLYCEROL HEX:HEXANE LMT:DODECYL-BETA-D-MALTOSIDE LMU:DODECYL-ALPHA-D-MALTOSIDE | |||
4k7q | [A3] | [A3] | [A3] | 3.5 | ZLD:N-{[(5S)-3-(3-FLUORO-4-MORPHOLIN-4-YLPHENYL)-2-OXO-1,3-OXAZOLIDIN-5-YL]METHYL}ACETAMIDE | |||
4mt1 | [A3] | [A3] | [A3] | 3.54 | ||||
4u8v | [A3B2] | [A3B2] | [A3B2] | 2.3 | LMT:DODECYL-BETA-D-MALTOSIDE MIY:(4S,4AS,5AR,12AS)-4,7-BIS(DIMETHYLAMINO)-3,10,12,12A-TETRAHYDROXY-1,11-DIOXO-1,4,4A,5,5A,6,11,12A-OCTAHYDROTETRACENE-2-CARBOXAMIDE | |||
4u8y | [A3B2] | [A3B2] | [A3B2] | 2.1 | LMT:DODECYL-BETA-D-MALTOSIDE MIY:(4S,4AS,5AR,12AS)-4,7-BIS(DIMETHYLAMINO)-3,10,12,12A-TETRAHYDROXY-1,11-DIOXO-1,4,4A,5,5A,6,11,12A-OCTAHYDROTETRACENE-2-CARBOXAMIDE | |||
4u95 | [A3B2] | [A3B2] | [A3B2] | 2 | LMT:DODECYL-BETA-D-MALTOSIDE MIY:(4S,4AS,5AR,12AS)-4,7-BIS(DIMETHYLAMINO)-3,10,12,12A-TETRAHYDROXY-1,11-DIOXO-1,4,4A,5,5A,6,11,12A-OCTAHYDROTETRACENE-2-CARBOXAMIDE | |||
4u96 | [A3B2] | [A3B2] | [A3B2] | 2.2 | LMT:DODECYL-BETA-D-MALTOSIDE | |||
4zit | [A3] | [A3] | [A3] | 3.3 | LMT:DODECYL-BETA-D-MALTOSIDE NI:NICKEL (II) ION | |||
4ziv | [A3] | [A3] | [A3] | 3.16 | LMT:DODECYL-BETA-D-MALTOSIDE NI:NICKEL (II) ION | |||
4ziw | [A3] | [A3] | [A3] | 3.4 | LMT:DODECYL-BETA-D-MALTOSIDE NI:NICKEL (II) ION | |||
4zjl | [A3] | [A3] | [A3] | 3.47 | ERY:ERYTHROMYCIN A LMT:DODECYL-BETA-D-MALTOSIDE NI:NICKEL (II) ION | |||
4zjo | [A3] | [A3] | [A3] | 3.6 | ERY:ERYTHROMYCIN A LMT:DODECYL-BETA-D-MALTOSIDE NI:NICKEL (II) ION | |||
4zjq | [A3] | [A3] | [A3] | 3.59 | ERY:ERYTHROMYCIN A LMT:DODECYL-BETA-D-MALTOSIDE NI:NICKEL (II) ION | |||
4zlj | [A3] | [A3] | [A3] | 3.26 | ||||
4zll | [A3] | [A3] | [A3] | 3.36 | ||||
4zln | [A3] | [A3] | [A3] | 3.56 | ||||
5jmn | [A3B2] | [A3B2] | [A3B2] | 2.5 | D10:DECANE D12:DODECANE ETE:2-{2-[2-2-(METHOXY-ETHOXY)-ETHOXY]-ETHOXY}-ETHANOL FUA:FUSIDIC ACID GOL:GLYCEROL HEX:HEXANE LMT:DODECYL-BETA-D-MALTOSIDE OCT:N-OCTANE P3G:3,6,9,12,15-PENTAOXAHEPTADECANE PTY:PHOSPHATIDYLETHANOLAMINE SO4:SULFATE ION | |||
5lq3 | [A3] | [A3] | [A3] | 3.55 | ||||
5nc5 | [A3B3C2] | [A3B3C2] | [A3B3C2] | 3.2 | D10:DECANE D12:DODECANE DD9:NONANE HEX:HEXANE LMT:DODECYL-BETA-D-MALTOSIDE PUY:PUROMYCIN | |||
5t0o | [A3] | [A3] | [A3] | 3.15 | ||||
5yil | [A3] | [A3] | [A3] | 3 | ||||
6baj | [A3] | [A3] | [A3] | 3.2 | D12:DODECANE PTY:PHOSPHATIDYLETHANOLAMINE |
*Chain Formula of OLIGAMI.
[ ] : Polypeptide - [AB] : Protein, [ab] : Small peptide
( ) : Nucleic acid - (AB) : DNA, (ab) : RNA
[ ] : Polypeptide - [AB] : Protein, [ab] : Small peptide
( ) : Nucleic acid - (AB) : DNA, (ab) : RNA